Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Oncoinvent gets IND clearance for both lead indications

Oncoinvent has secured IND clearance from the FDA for both of the planned phase IIb clinical trials with Radspherin in patients with peritoneal carcinomatosis from colorectal cancer and ovarian cancer. This marks a milestone allowing Oncoinvent to clinically advance Radspherin and expand to the US landscape. BioStock reached out to CEO Anders Månsson to find out more about the development strategy.Read the full article at biostock.se: https://www.biostock.se/en/2023/11/oncoinvent-gets-ind-clearance-for-both-lead-indications/ This is a press release from BioStock - Connecting

Careium implements organisational changes for stronger commercial development and changes the management of its Swedish operations.

Careium appoints Martin Puumalainen, currently Head of Nordic and Export Markets, to the role of Chief Commercial Officer, with responsibility for the commercial development of all regions and central marketing and sales functions. Martin will start on December 1, 2023, and will be responsible for consolidating the company's commercial activities, creating an enhanced interface between R&D, the Supply Chain, and the market, and strategically leading the company's sales development. “During his years in the business, Martin has created great value and strong sales development, especially

Yggdrasil: Construction of Munin platform has started

On Thursday 2 November, Aker BP and Aibel celebrated the first steel cut for the Munin platform in Thailand. Thai monks blessed the steel in a formal ceremony, before construction of the unmanned production platform got underway.     “After many years of planning and engineering, construction of Munin is now starting according to plan. The Munin team has made an incredible effort to get the steel cutting started. It was a great experience to take part in the celebration today, which also marks that construction activity is under way on all platform deliveries in Yggdrasil. This

atNorth Joins the Finnish Data Center Association (FDCA)

atNorth joins the FDCA to contribute to the sustainable future of the Finnish Data Center IndustryReykjavik, Iceland – November 2[nd], 2023 – atNorth, a leading Nordic colocation, high-performance computing, and artificial intelligence service provider, today announced it joined the Finnish Data Center Association (FDCA). The association aims to nurture the fast growing data center ecosystem in Finland, and enhance the standardization and sustainability of its industry processes. The business acquired two data centers in Helsinki, Finland in January and has a third site, which will open

Interim Report Q3 - Ayima Group AB

Highlights  3rd Quarter: Jul - Sep 2023 · Revenue amounted to 29.4 MSEK (37.7), a decrease of 22% from the corresponding period in 2022 · Gross Profit amounted to 14.9 MSEK (22.2), a decrease of 33% from the corresponding period in 2022  · Operating costs amounted to 14.6 MSEK (20.5), a reduction of 29% from the corresponding period last year · A positive EBITDA result of 0.4 MSEK (1.7)  · Net Profit after tax for the period was -3.5 MSEK (-2.1) Year: Jan - Sep 2023 · Revenue amounted to 94.8 MSEK (110.9), a decrease of 14% from the same period in 2022 · Gross

Multiconsult acquires Planteknikk AS

Multiconsult ASA (OSE: MULTI)Planteknikk AS is a consulting engineering company specialising in HVAC with a solid reputation and presence in the county Østfold, Norway. In the financial year 2022 the acquired company reported an operating revenues of NOK 8.6 million with an EBIT of NOK 1.5 million.For further information, please contact:Investor relations:Pål-Sverre Jørgensen, Group Treasurer & IROPhone: +47 416 11 161E-mail: psmj@multiconsult.no  / ir@multiconsult.no Media:Gaute Christensen, VP CommunicationsPhone: +47 911 70 188E-mail: gaute.christensen@multiconsult.no

Study reveals opioid treatment barriers in high-risk users in Finland

A recent study shows that many high-risk opioid users do not enter treatment even though the most common reason for opioid use is self-medication for withdrawal symptoms[1]. The study uncovered several barriers hindering access to treatment, urging immediate action to address this critical trend in Finland. Over the past decade, Finland has witnessed a significant rise in opioid misuse, doubling the number of high-risk opioid users. In recent years, opioids have been involved in approximately 70% of fatal overdoses in Finland, especially among individuals under 25 years of age[2]. This

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc Stock Exchange Release 2 November 2023 at 10.00, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from Universal-Investment-Gesellschaft mit beschränkter Haftung (“Notifier”). According to the notification, the total holdings in Optomed shares and votes held by Notifier is 4.98 per cent of all of the registered shares in Optomed on 31 October

Wärtsilä supports Denmark’s green energy future with opening of new biogas liquefaction plant

Wärtsilä Corporation, Trade press release, 2 November 2023 at 10 AM EETTechnology group Wärtsilä has engineered, delivered, and installed the biogas upgrading solution to a new biogas 17 tons per day liquefaction plant in Hjørring, Denmark. The contract was awarded to Wärtsilä in 2022, and the official start-up took place in June 2023. The facility is one of two biogas plants owned and operated by GrønGas A/S in Denmark. The other plant, located in Vrå, also features a Wärtsilä biogas upgrading solution . The plant in Hjørring has an

SSAB to deliver future fossil-free steel to Sandvik for loaders and trucks

SSAB and Sandvik Mining and Rock Solutions have signed a letter of intent to secure fossil-free steel for use initially in the production of Sandvik’s loaders and trucks. One of Sandvik’s battery-electric loaders. Photo: Sandvik SSAB aims to deliver fossil-free steel to the market in commercial scale during 2026, and the letter of intent ensures Sandvik secures its needed volumes within SSAB’s production capacity. As a fossil-free partner to SSAB, Sandvik can also apply for early fossil-free sample deliveries of, for example, a prototype frame, loader bucket or truck box to be

Kuva Space raises €16.6M funding round to launch its microsatellite constellation and observe the molecular composition of any material on Earth

Funding from Voima Ventures, Nordic Foodtech VC, Earth VC, Springvest, and Business Finland propel Kuva Space into a new phase of expansion and innovation, bringing hyperspectral insights about built and natural assets on Earth from space.ESPOO, Finland (November 2nd, 2023) Finnish Earth observation company Kuva Space  has successfully raised €16.6M in funding. The funding round was led by existing investors Voima Ventures and Nordic Foodtech VC, with Singapore-based Earth VC also participating. The round also includes Finnish private investors through a Finland-

BioStock: Medivir’s CEO comments on the updated clinical data

Medivir continues to make strides with its drug candidate fostrox, targeting primary liver cancer. In the Q3 report published last week, and in a subsequent webcast, the company presented detailed interim data from its phase Ia/IIb study. This data clearly demonstrates increased clinical benefit when fostrox is added to the current standard of care therapy in second-line, Lenvima, compared to Lenvima monotherapy. BioStock reached out to the company's CEO, Jens Lindberg, for a comment on this promising milestone data.Read the full interview with Medivir's CEO Jens Lindberg at biostock.se:

Veg of Lund has applied for patent protection for its plant-based meat alternative

Veg of Lund expands its patent portfolio by applying for a Swedish patent for the product and method of producing a so-called meat analogue, which is a vegetable alternative to red and white meat. The company already has patents for its potato drink and smoothie sold under the name DUG, as well as for its plant-based ice cream and cream products.The company’s development of food products based on potatoes is led by Eva Tornberg, the company’s Head of Research & Development. Eva Tornberg is one of the founders of Veg of Lund and her knowledge of emulsions is the key to the company’s plant-

Interim Report third quarter 2023

· Net sales declined to SEK 3,101m (3,480). · On an organic basis, sales declined by -18% (4). · Operating profit amounted to SEK 132m (78). · Operating profit excl. items affecting comparability (IAC) was SEK 51m (78). · IAC amounted to SEK 81m and mainly refer to a capital gain from sale of theDewsbury factory (SEK 112m) and factory transition cost in the Nordic region (SEK -27m). · The decline in operating profit, excl. IAC, was largely due to the sales volume decline,which is estimated to be in line with market development. · The operating margin amounted to 4.3% (2.

Beijer Ref acquires Turner Engineering in Australia

Beijer Ref (publ) ("Beijer Ref") has signed an agreement to acquire 100 per cent of the shares in Turner Engineering, an HVAC distributor with more than 45 years of experience. The company has an annual turnover of approximately SEK 200 million. Turner Engineering was founded in 1974 and is headquartered in Perth (Western Australia). The company, which is among the region's longest-standing independent HVAC distributors, boasts a highly proficient team comprising HVAC specialists, technicians and engineers. This acquisition aligns with Beijer Ref’s overall acquisition strategy and

The exercise period for warrants of series TO3 starts today

Today, November 2, 2023 the exercise period for warrants of series TO3 begins in PEPTONIC medical AB ("Peptonic" or the "Company"). The exercise period lasts until November 16, 2023.NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTIONS BEYOND THOSE REQUIRED BY SWEDISH LAW.   Summarized terms for the warrants of series TO3: Exercise period:

Gaming Innovation Group appoints Andrew Cochrane as new Chief Business Officer for Platform & Sportsbook

Gaming Innovation Group (GiG) has announced former SBTech and DraftKings executive Andrew Cochrane as its new Chief Business Officer (CBO) for Platform & Sportsbook, marking a significant step in the tech providers’ ambitious growth plans. A prominent and highly respected figure within the industry, Andrew brings to GiG a wealth of experience at delivering commercial successes, having played pivotal roles in SBTech’s impressive revenue growth and establishing DraftKings’ preeminent position as market leaders across the US. Andrew is renowned in the industry as a customer relations expert,

MapsPeople A/S: Change in management

MapsPeople A/S | Changes board/management/certified advisors Company Announcement No.  26-2023 Aalborg, November 2, 2023Change in Management Today, MapsPeople announced that the company has initiated a search for a new CFO, as Jesper Lund Tidemand has decided to resign from his position. Jesper Lund Tidemand will continue as CFO for MapsPeople until the end of January 2024.   FURTHER INFORMATION MapsPeople A/S Morten Brøgger, CEO  Mobile (+45) 31 23 48 72  Email mobr@mapspeople.com   Stigsborgvej 60, 9400 Nørresundby  Denmark Certified Advisor Grant

Alfa Laval – Capturing the potential in the hydrogen sector

Alfa Laval is establishing a new business unit – Business Unit Electrolyzer and Fuel Cell Technologies – with the aim of capturing business opportunities in the hydrogen sector. This initiative underlines the company’s commitment to driving the energy transformation towards clean energy sources.Over the past three years, Alfa Laval has been present in the hydrogen market, pioneering products and solutions in the areas of electrolyzers and fuel cells. Recognizing the potential, Alfa Laval has decided to establish a new business unit and develop new products and solutions in hydrogen

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 186 - 2 NOVEMBER 2023 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 30 million (approximately DKK 210 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was granted at NORDEN’s general meeting on 9 March 2023.   Purpose The purpose of the share

NORDEN reports net profit of USD 99 million in Q3 2023 and continues to return cash to shareholders

ANNOUNCEMENT NO. 185 - 2 NOVEMBER 2023 For Q3 2023, NORDEN reports a profit of USD 99 million (approx. DKK 700 million). For the first nine-months of 2023 net profit amounted to USD 357 million (approx. DKK 2.5 billion). Free cash flow before acquisitions and financial assets in Q3 amounted to USD 109 million (approx. DKK 770 million). For the first nine-months of 2023, free cash flow before acquisitions and financial assets amounted to USD 305 million (approx. DKK 2.2 billion). Return on equity (annualised) was 27% at the end of Q3 and was 35% for the first nine-months of 2023.

BioStock: Strong Q3 performance for Alligator Bioscience

Alligator Bioscience has reported a productive quarter, showing significant advancements in its cancer therapeutics pipeline, particularly its lead asset mitazalimab, which received Orphan Designation in Europe. Moreover, the company reached another milestone in its partnership with Orion Corporation and strengthened its financial foundation through a successful warrant exercise. The stage is set for a promising final quarter of the year, with key data slated for release in early 2024. BioStock spoke with CEO Søren Bregenholt to learn more.Read the interview with Søren Bregenholt at

Updates on Remondis transaction and bond redemption

Delete Group Oyj | Stock Exchange Release| 2 November 2023 at 9:15 a.m. EETDelete Group Oyj ("Delete") announced on 12 May 2023 that its shareholders had signed a binding sale and purchase agreement with Remondis Maintenance & Services International GmbH regarding the sale of all the shares in Delete (the "Transaction"). Moreover, Delete announced that it would, subject to obtaining all customary closing conditions, including approvals by relevant competition authorities required to complete the Transaction (the "Competition Clearances"), voluntarily redeem (the "Redemption") all its

AFRY awarded two framework agreements for Statnett in Norway

Advansia, part of AFRY, is the contractual part of the two framework agreements. The agreements are aimed at facilitating the further development and expansion of the transmission network in Norway and includes both project management services and detailed engineering services.Statnett, the state-owned enterprise responsible for Norway's power transmission system, must renew and improve the main power grid across the country. A robust and well-functioning power grid is important for enabling the green shift and a sustainable value creation, as well as securing the power capacity and supply.

There are no items matching the current filter
There are no more items matching the current filter
Back to top